BEAM conditioning regimen ensures better progression-free survival compared with TEAM but not with FEAM in lymphoma patients undergoing autologous stem cell transplant.

Francesco Marchesi,Saveria Capria,Mariangela Pedata,Irene Terrenato,Laura Ballotta,Cira Riccardi,Elena Papa,Costantino Riemma,Silvia Maria Trisolini,Maria Celentano,Giulia Regazzo,Felicetto Ferrara,Andrea Mengarelli,Alessandra Picardi

BEAM conditioning regimen ensures better progression-free survival compared with TEAM but not with FEAM in lymphoma patients undergoing autologous stem cell transplant.

2020

Francesco Marchesi
Saveria Capria
Mariangela Pedata
Irene Terrenato
Laura Ballotta
Cira Riccardi
Elena Papa
Costantino Riemma
Silvia Maria Trisolini
Maria Celentano
Giulia Regazzo
Felicetto Ferrara
Andrea Mengarelli
Alessandra Picardi

BEAM conditioning regimen (Carmustine, Etoposide, Cytarabine and Melphalan) is the currently standard for lymphoma patients undergoing an autologous hematopoietic stem cell transplant (ASCT) [1–2]....

Keywords:

Internal medicine
conditioning regimen
Progression-free survival
Stem cell
Oncology
Medicine
Immunology
Lymphoma
Diabetes mellitus

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations